{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:37:33Z","timestamp":1794379053716,"version":"4.9.0"},"reference-count":45,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T00:00:00Z","timestamp":1638057600000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["APP1162874"],"award-info":[{"award-number":["APP1162874"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,11,8]]},"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Knee osteoarthritis (KOA) is a highly prevalent disabling joint disease. Intra-articular stem cell therapy is increasingly being used for treating KOA with little high-quality evidence to support its use. The aim of this study is to investigate the efficacy, safety and cost-effectiveness of allogeneic mesenchymal stem cells (Cymerus MSCs) for treating symptomatic tibiofemoral KOA and improving knee structure over 24 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Stem Cell injections for symptomatic relief and strUctural improvement in people with Tibiofemoral knee OsteoaRthritis study is a phase III, multi-centre, parallel, superiority, randomised, double-blind, placebo-controlled trial, which will be conducted in Sydney and Hobart, Australia. 440 participants (220 per arm) aged over 40 years with painful KOA and mild to moderate structural change on X-ray (Kellgren and Lawrence grade 2 or 3) with medial minimum joint space width between 1 and 4\u2009mm in the study knee will be recruited from the community and randomly allocated to receive either intra-articular MSCs or saline at baseline, week 3 and week 52. The coprimary outcomes will be the proportion of participants achieving patient-acceptable symptom state for knee pain at 24 months and quantitative central medial femorotibial compartment cartilage thickness change from baseline to 24 months. Main secondary outcomes include change in knee pain, Patient Global Assessment, physical function, quality of life and other structural changes. Additional data for cost-effectiveness analysis will also be recorded. Adverse events will be monitored throughout the study. The primary analysis will be conducted using modified intention-to-treat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This protocol has been approved by The University of Sydney (USYD) Human Research Ethics Committee (HREC) #: 2020\/119 and The University of Tasmania (UTAS) HREC #: H0021868. All participants will be required to provide informed consent. Dissemination will occur through conferences, social media, and scientific publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>Australian New Zealand Clinical Trials Registry (ACTRN12620000870954); U1111-1234-4897.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056382","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T11:11:59Z","timestamp":1638184319000},"page":"e056382","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and cost-effectiveness of Stem Cell injections for symptomatic relief and strUctural improvement in people with Tibiofemoral knee OsteoaRthritis: protocol for a randomised placebo-controlled trial (the SCUlpTOR trial)"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6375-1800","authenticated-orcid":false,"given":"Xiaoqian","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Robbins","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-9390","authenticated-orcid":false,"given":"Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Virk","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Schuck","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia A","family":"Deveza","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Win Min","family":"Oo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Carmichael","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Antony","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Eckstein","sequence":"additional","affiliation":[{"name":"Institute of Anatomy and Cell Biology and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria"},{"name":"Chondrometrics GmbH, Freilassing, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wirth","sequence":"additional","affiliation":[{"name":"Institute of Anatomy and Cell Biology and Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria"},{"name":"Chondrometrics GmbH, Freilassing, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Little","sequence":"additional","affiliation":[{"name":"Raymond Purves Bone and Joint Research Labs, Kolling Institute of Medical Research, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Linklater","sequence":"additional","affiliation":[{"name":"Castlereagh Imaging, St Leonards, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-3320","authenticated-orcid":false,"given":"Anthony","family":"Harris","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, Monash University, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Humphries","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Health and Medicine, University of Tasmania Faculty of Health, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"O\"Connell","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Heller","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Buttel","sequence":"additional","affiliation":[{"name":"Representative of People with Knee Osteoarthritis, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5424-9448","authenticated-orcid":false,"given":"Stefan","family":"Lohmander","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Lund, Orthopaedics, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhai","family":"Ding","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia"},{"name":"Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-752X","authenticated-orcid":false,"given":"David J","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Institute of Bone and Joint Research, Kolling Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia"},{"name":"Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"2025121401000926000_11.11.e056382.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60802-3"},{"key":"2025121401000926000_11.11.e056382.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216515"},{"key":"2025121401000926000_11.11.e056382.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1903768"},{"key":"2025121401000926000_11.11.e056382.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.44"},{"key":"2025121401000926000_11.11.e056382.5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1703856114"},{"key":"2025121401000926000_11.11.e056382.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204763"},{"key":"2025121401000926000_11.11.e056382.7","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1801453"},{"key":"2025121401000926000_11.11.e056382.8","first-page":"53","article-title":"The projected burden of knee osteoarthritis in New Zealand: healthcare expenditure and total joint replacement provision","volume":"132","author":"Wilson","year":"2019","journal-title":"N Z Med J"},{"key":"2025121401000926000_11.11.e056382.9","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1231"},{"key":"2025121401000926000_11.11.e056382.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1225"},{"key":"2025121401000926000_11.11.e056382.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30417-9"},{"key":"2025121401000926000_11.11.e056382.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2016-096793"},{"key":"2025121401000926000_11.11.e056382.13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0037-1604443","article-title":"The stem-cell market for the treatment of knee osteoarthritis: a patient perspective","volume":"31","author":"Piuzzi","year":"2018","journal-title":"J Knee Surg"},{"key":"2025121401000926000_11.11.e056382.14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jcyt.2019.10.004","article-title":"Mesenchymal stem cells in the treatment of articular cartilage degeneration: new biological insights for an old-timer cell","volume":"21","author":"Colombini","year":"2019","journal-title":"Cytotherapy"},{"key":"2025121401000926000_11.11.e056382.15","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2017-0152"},{"key":"2025121401000926000_11.11.e056382.16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/rme-2018-0161","article-title":"Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial","volume":"14","author":"Freitag","year":"2019","journal-title":"Regen Med"},{"key":"2025121401000926000_11.11.e056382.17","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0053"},{"key":"2025121401000926000_11.11.e056382.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-020-02530-6","article-title":"Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis","volume":"18","author":"Lamo-Espinosa","year":"2020","journal-title":"J Transl Med"},{"key":"2025121401000926000_11.11.e056382.19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jcyt.2018.08.005","article-title":"Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial","volume":"20","author":"Emadedin","year":"2018","journal-title":"Cytotherapy"},{"key":"2025121401000926000_11.11.e056382.20","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.23242"},{"key":"2025121401000926000_11.11.e056382.21","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1080\/14656566.2016.1232396","article-title":"Intra-articular therapies for osteoarthritis","volume":"17","author":"Yu","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2025121401000926000_11.11.e056382.22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s00167-018-5118-9","article-title":"Injective mesenchymal stem cell-based treatments for knee osteoarthritis: from mechanisms of action to current clinical evidences","volume":"27","author":"Lopa","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2025121401000926000_11.11.e056382.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101401"},{"key":"2025121401000926000_11.11.e056382.24","doi-asserted-by":"publisher","DOI":"10.1080\/14653240600855905"},{"key":"2025121401000926000_11.11.e056382.25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","article-title":"Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study","volume":"26","author":"Bloor","year":"2020","journal-title":"Nat Med"},{"key":"2025121401000926000_11.11.e056382.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2021.07.016","article-title":"Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction","author":"Thavapalachandran","year":"2021","journal-title":"Cytotherapy"},{"key":"2025121401000926000_11.11.e056382.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290816"},{"key":"2025121401000926000_11.11.e056382.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.023028"},{"key":"2025121401000926000_11.11.e056382.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2008.07.008"},{"key":"2025121401000926000_11.11.e056382.30","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8020221","article-title":"Current status and changes in pain and activities of daily living in elderly patients with osteoarthritis before and after unilateral total knee replacement surgery","volume":"8","author":"Lai","year":"2019","journal-title":"J Clin Med"},{"key":"2025121401000926000_11.11.e056382.31","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-64"},{"key":"2025121401000926000_11.11.e056382.32","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-199905000-00001"},{"key":"2025121401000926000_11.11.e056382.33","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-013-0036-x"},{"key":"2025121401000926000_11.11.e056382.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2011.05.004"},{"key":"2025121401000926000_11.11.e056382.35","doi-asserted-by":"publisher","DOI":"10.1179\/jmt.2009.17.3.163"},{"key":"2025121401000926000_11.11.e056382.36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40258-019-00512-4","article-title":"A review of the development and application of generic Preference-Based instruments with the older population","volume":"17","author":"Cleland","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"2025121401000926000_11.11.e056382.37","unstructured":"Pereira A , Gossuin C , Helleputte T . Method for prediction of a placebo response in an individual, 2017. Available: Patent US 15\/308,502; US2017\/0053082"},{"key":"2025121401000926000_11.11.e056382.38","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jpain.2016.01.074","article-title":"(171) characterization and prediction of placebo responders in peripheral neuropathic patients in a 4-week analgesic clinical trial","volume":"17","author":"Pereira","year":"2016","journal-title":"J Pain"},{"key":"2025121401000926000_11.11.e056382.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.05.012"},{"key":"2025121401000926000_11.11.e056382.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110307"},{"key":"2025121401000926000_11.11.e056382.41","doi-asserted-by":"publisher","DOI":"10.1186\/ar2118"},{"key":"2025121401000926000_11.11.e056382.42","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/art.39324","article-title":"Brief report: cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: data from the foundation for the National Institutes of health osteoarthritis biomarkers Consortium","volume":"67","author":"Eckstein","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025121401000926000_11.11.e056382.43","first-page":"1188","article-title":"Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders","volume":"34","author":"Tubach","year":"2007","journal-title":"J Rheumatol"},{"key":"2025121401000926000_11.11.e056382.44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10543406.2017.1378668","article-title":"Design, data monitoring, and analysis of clinical trials with co-primary endpoints: a review","volume":"28","author":"Hamasaki","year":"2018","journal-title":"J Biopharm Stat"},{"key":"2025121401000926000_11.11.e056382.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2007.01.008"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:00:20Z","timestamp":1765702820000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,29]]},"published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1136\/bmjopen-2021-056382"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056382","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056382.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056382.supp2","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}